BioCentury
ARTICLE | Company News

EffRx, Kadmon deal

March 24, 2014 7:00 AM UTC

Drug delivery company EffRx will develop effervescent formulations of products to be developed by Kadmon in adult and pediatric Orphan indications. Kadmon has rights from Valeant Pharmaceuticals Inte...